Antila Bioscience Private Limited
About Antila Bioscience Private Limited
Data last updated:
Antila Bioscience Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2013PTC076354. Its GSTIN is 24AAMCA2392J1ZI (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jasmine Vijay Shah and Sanjay Jashwantlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 815 Devpath Complex B/H Lal Bunglow Off C. G. Road, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.01 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net profit of ₹2.32 Lakh (net margin 6.8%) and EBITDA of ₹3.36 Lakh (EBITDA margin 9.9%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 17% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address815 Devpath Complex B/H Lal Bunglow Off C. G. Road, Ahmedabad, Gujarat, India – 380006
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Antila Bioscience Private Limited
The main business activity of Antila Bioscience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Antila Bioscience Private Limited FY 2025 filings available
Antila Bioscience Private Limited reported revenue of ₹34.01 Lakh (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Antila Bioscience Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 65% fall in the latest year. EBITDA fell 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Antila Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.36 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.32 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Antila Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Antila Bioscience are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Antila Bioscience Private Limited
Antila Bioscience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunbiosmith Pharmaceuticals Private Limited | ₹34.24 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Dehradun, Uttarakhand, India |
| Ampel Healthcare Private Limited | ₹34.23 Lakh (FY 2023) | •••• | •••• | 126.0% | •••• | Patna, Bihar, India |
| Alixion Pharmaceuticals India Private Limited | ₹34.21 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Sonipat, Haryana, India |
| Zeylanica Pharmaceuticals Private Limited | ₹34.05 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Vadodara, Gujarat, India |
| Bosone Pharma Vision Private Limited | ₹34.04 Lakh (FY 2023) | •••• | •••• | 35.0% | •••• | New Delhi, Delhi, India |
| Antila Bioscience Private Limited this company | ₹34.01 Lakh (FY 2025) | •••• | •••• | -65.0% | •••• | Ahmedabad, Gujarat, India |
| DMVM Drugs Private Limited | ₹33.98 Lakh (FY 2025) | •••• | •••• | 2420.0% | •••• | Delhi, India |
| Khanal Industries Private Limited | ₹33.94 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Bengaluru, Karnataka, India |
| Adhisvar Pharmaceuticals Private Limited | ₹33.85 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Vadodara, Gujarat, India |
| Elite Medicare Private Limited | ₹33.82 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Ahmedabad, Gujarat, India |
| LN Pharmaceuticals Private Limited | ₹33.71 Lakh (FY 2025) | •••• | •••• | 447.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Antila Bioscience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Antila Bioscience Private Limited
Antila Bioscience Private Limited is audited by UDAY I. SHAH & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| UDAY I. SHAH & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Antila Bioscience Private Limited
Antila Bioscience has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jasmine Vijay Shah | Director | 13 Dec 2016 | 9 Years 9 Months | Current |
| Sanjay Jashwantlal Shah Also directs: Calyxen Bioscience Private Limited, Antila Lifesciences Private Limited, Espee Pharma Chem Private Limited and 1 more | Director | 08 Aug 2013 | 13 Years 2 Months | Current |
Ownership and Shareholding of Antila Bioscience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Antila Bioscience Private Limited
Antila Bioscience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Antila Bioscience Private Limited
Employment history and EPFO contributions of people linked to Antila Bioscience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Antila Bioscience Private Limited
Antila Bioscience Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Jignesh Rajendra Sanghavi ceased to be Director on 30 Jan 2023.
Credit Ratings, Litigation & Regulatory Alerts for Antila Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Antila Bioscience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Antila Bioscience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Antila Bioscience Private Limited
Antila Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAMCA2392J1ZI | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Antila Bioscience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antila Bioscience Private Limited
Antila Bioscience is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2013 (13+ years old) and is registered under CIN U24233GJ2013PTC076354.
Antila Bioscience reported revenue of ₹34.01 Lakh for FY 2025 (down 65% YoY).
Antila Bioscience has 2 current directors:
- Jasmine Vijay Shah - Director
- Sanjay Jashwantlal Shah - Director
Antila Bioscience reported a net profit of ₹2.32 Lakh (net margin 6.8%) and EBITDA of ₹3.36 Lakh (EBITDA margin 9.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Antila Bioscience is -24% over three years and -17% over five years. In the latest year (FY 2025) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Antila Bioscience is 24AAMCA2392J1ZI, registered in Gujarat.
The CIN (Corporate Identification Number) of Antila Bioscience is U24233GJ2013PTC076354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Antila Bioscience was incorporated on 08 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Antila Bioscience by revenue are Sunbiosmith Pharmaceuticals Private Limited, Ampel Healthcare Private Limited, Alixion Pharmaceuticals India Private Limited, Zeylanica Pharmaceuticals Private Limited, Bosone Pharma Vision Private Limited and 5 more, all in the Pharma industry (Formulations).
Jignesh Rajendra Sanghavi ceased to be Director on 30 Jan 2023. Sanjaybhai Kanubhai Prajapati ceased to be Director on 30 Jan 2023. Jasmine Vijay Shah ceased to be Additional Director on 26 Sep 2017. Antila Bioscience has 7 board changes on record in total.
The registered office of Antila Bioscience is at 815 Devpath Complex BH Lal Bunglow Off C. G. Road, Ahmedabad, Gujarat, India – 380006.